 | • レポートコード：GIR201108030 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、リバロキサバンの世界市場を調査対象にし、リバロキサバンの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（2.5mg、10mg、15mg、20mg）、用途別分析（急性冠症候群（ACS）、静脈血栓塞栓症（VTE））、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Bayer、J&J ・メーカー別販売量、売上、市場シェア ・リバロキサバンの地域別市場分析 ・リバロキサバンの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・リバロキサバンのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・リバロキサバンのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・リバロキサバンの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・リバロキサバンの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・リバロキサバンの種類別市場規模2015-2020：2.5mg、10mg、15mg、20mg ・リバロキサバンの用途別市場規模2015-2020：急性冠症候群（ACS）、静脈血栓塞栓症（VTE） ・リバロキサバンの世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The Rivaroxaban market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Rivaroxaban market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.8%% in the forecast period of 2020 to 2025 and will expected to reach USD 9616.8 million by 2025, from USD 7108.7 million in 2019.
Market segmentation
Rivaroxaban market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Rivaroxaban market has been segmented into
2.5 mg
10 mg
15 mg
20 mg
By Application, Rivaroxaban has been segmented into:
Acute Coronary Syndrome (ACS)
Venous Thromboembolism (VTE)
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Rivaroxaban market presented in the report. This section sheds light on the sales growth of different regional and country-level Rivaroxaban markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Rivaroxaban market.
The report offers in-depth assessment of the growth and other aspects of the Rivaroxaban market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Rivaroxaban Market Share Analysis
Rivaroxaban competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Rivaroxaban sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Rivaroxaban sales, revenue and market share for each player covered in this report.
The major players covered in Rivaroxaban are:
Bayer
J&J
Among other players domestic and global, Rivaroxaban market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Rivaroxaban product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Rivaroxaban, with price, sales, revenue and global market share of Rivaroxaban in 2018 and 2019.
Chapter 3, the Rivaroxaban competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rivaroxaban breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Rivaroxaban market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Rivaroxaban sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Rivaroxaban Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Rivaroxaban Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 2.5 mg
1.2.3 10 mg
1.2.4 15 mg
1.2.5 20 mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Rivaroxaban Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Acute Coronary Syndrome (ACS)
1.3.3 Venous Thromboembolism (VTE)
1.4 Overview of Global Rivaroxaban Market
1.4.1 Global Rivaroxaban Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer SWOT Analysis
2.1.4 Bayer Product and Services
2.1.5 Bayer Rivaroxaban Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 J&J
2.2.1 J&J Details
2.2.2 J&J Major Business
2.2.3 J&J SWOT Analysis
2.2.4 J&J Product and Services
2.2.5 J&J Rivaroxaban Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Rivaroxaban Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Rivaroxaban Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Rivaroxaban Manufacturer Market Share in 2019
3.3.2 Top 6 Rivaroxaban Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Rivaroxaban Sales, Revenue and Market Share by Regions
4.1.1 Global Rivaroxaban Sales and Market Share by Regions (2015-2020)
4.1.2 Global Rivaroxaban Revenue and Market Share by Regions (2015-2020)
4.2 North America Rivaroxaban Sales and Growth Rate (2015-2020)
4.3 Europe Rivaroxaban Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Rivaroxaban Sales and Growth Rate (2015-2020)
4.5 South America Rivaroxaban Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Rivaroxaban Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Rivaroxaban Sales, Revenue and Market Share by Country
5.1.1 North America Rivaroxaban Sales and Market Share by Country (2015-2020)
5.1.2 North America Rivaroxaban Revenue and Market Share by Country (2015-2020)
5.2 United States Rivaroxaban Sales and Growth Rate (2015-2020)
5.3 Canada Rivaroxaban Sales and Growth Rate (2015-2020)
5.4 Mexico Rivaroxaban Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Rivaroxaban Sales, Revenue and Market Share by Country
6.1.1 Europe Rivaroxaban Sales and Market Share by Country (2015-2020)
6.1.2 Europe Rivaroxaban Revenue and Market Share by Country (2015-2020)
6.2 Germany Rivaroxaban Sales and Growth Rate (2015-2020)
6.3 UK Rivaroxaban Sales and Growth Rate (2015-2020)
6.4 France Rivaroxaban Sales and Growth Rate (2015-2020)
6.5 Russia Rivaroxaban Sales and Growth Rate (2015-2020)
6.6 Italy Rivaroxaban Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Rivaroxaban Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Rivaroxaban Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Rivaroxaban Revenue and Market Share by Regions (2015-2020)
7.2 China Rivaroxaban Sales and Growth Rate (2015-2020)
7.3 Japan Rivaroxaban Sales and Growth Rate (2015-2020)
7.4 Korea Rivaroxaban Sales and Growth Rate (2015-2020)
7.5 India Rivaroxaban Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Rivaroxaban Sales and Growth Rate (2015-2020)
7.7 Australia Rivaroxaban Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Rivaroxaban Sales, Revenue and Market Share by Country
8.1.1 South America Rivaroxaban Sales and Market Share by Country (2015-2020)
8.1.2 South America Rivaroxaban Revenue and Market Share by Country (2015-2020)
8.2 Brazil Rivaroxaban Sales and Growth Rate (2015-2020)
8.3 Argentina Rivaroxaban Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Rivaroxaban Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Rivaroxaban Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Rivaroxaban Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Rivaroxaban Sales and Growth Rate (2015-2020)
9.3 Turkey Rivaroxaban Sales and Growth Rate (2015-2020)
9.4 Egypt Rivaroxaban Sales and Growth Rate (2015-2020)
9.5 South Africa Rivaroxaban Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Rivaroxaban Sales and Market Share by Type (2015-2020)
10.2 Global Rivaroxaban Revenue and Market Share by Type (2015-2020)
10.3 Global Rivaroxaban Price by Type (2015-2020)
11 Global Rivaroxaban Market Segment by Application
11.1 Global Rivaroxaban Sales Market Share by Application (2015-2020)
11.2 Global Rivaroxaban Revenue Market Share by Application (2015-2020)
11.3 Global Rivaroxaban Price by Application (2015-2020)
12 Market Forecast
12.1 Global Rivaroxaban Sales, Revenue and Growth Rate (2021-2025)
12.2 Rivaroxaban Market Forecast by Regions (2021-2025)
12.2.1 North America Rivaroxaban Market Forecast (2021-2025)
12.2.2 Europe Rivaroxaban Market Forecast (2021-2025)
12.2.3 Asia-Pacific Rivaroxaban Market Forecast (2021-2025)
12.2.4 South America Rivaroxaban Market Forecast (2021-2025)
12.2.5 Middle East & Africa Rivaroxaban Market Forecast (2021-2025)
12.3 Rivaroxaban Market Forecast by Type (2021-2025)
12.3.1 Global Rivaroxaban Sales Forecast by Type (2021-2025)
12.3.2 Global Rivaroxaban Market Share Forecast by Type (2021-2025)
12.4 Rivaroxaban Market Forecast by Application (2021-2025)
12.4.1 Global Rivaroxaban Sales Forecast by Application (2021-2025)
12.4.2 Global Rivaroxaban Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Rivaroxaban Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Rivaroxaban by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Rivaroxaban Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Rivaroxaban Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Bayer Basic Information, Manufacturing Base and Competitors
Table 9. Bayer Rivaroxaban Major Business
Table 10. Bayer Rivaroxaban Total Revenue (USD Million) (2018-2019)
Table 11. Bayer SWOT Analysis
Table 12. Bayer Rivaroxaban Product and Services
Table 13. Bayer Rivaroxaban Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. J&J Basic Information, Manufacturing Base and Competitors
Table 15. J&J Rivaroxaban Major Business
Table 16. J&J Rivaroxaban Total Revenue (USD Million) (2018-2019)
Table 17. J&J SWOT Analysis
Table 18. J&J Rivaroxaban Product and Services
Table 19. J&J Rivaroxaban Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Global Rivaroxaban Sales by Manufacturer (2018-2019) (M Units)
Table 21. Global Rivaroxaban Revenue by Manufacturer (2018-2019) (USD Million)
Table 22. Global Rivaroxaban Sales by Regions (2015-2020) (M Units)
Table 23. Global Rivaroxaban Sales Market Share by Regions (2015-2020)
Table 24. Global Rivaroxaban Revenue by Regions (2015-2020) (USD Million)
Table 25. North America Rivaroxaban Sales by Countries (2015-2020) (M Units)
Table 26. North America Rivaroxaban Sales Market Share by Countries (2015-2020)
Table 27. North America Rivaroxaban Revenue by Countries (2015-2020) (USD Million)
Table 28. North America Rivaroxaban Revenue Market Share by Countries (2015-2020)
Table 29. Europe Rivaroxaban Sales by Countries (2015-2020) (M Units)
Table 30. Europe Rivaroxaban Sales Market Share by Countries (2015-2020)
Table 31. Europe Rivaroxaban Revenue by Countries (2015-2020) (USD Million)
Table 32. Asia-Pacific Rivaroxaban Sales by Regions (2015-2020) (M Units)
Table 33. Asia-Pacific Rivaroxaban Sales Market Share by Regions (2015-2020)
Table 34. Asia-Pacific Rivaroxaban Revenue by Regions (2015-2020) (USD Million)
Table 35. South America Rivaroxaban Sales by Countries (2015-2020) (M Units)
Table 36. South America Rivaroxaban Sales Market Share by Countries (2015-2020)
Table 37. South America Rivaroxaban Revenue by Countries (2015-2020) (USD Million)
Table 38. South America Rivaroxaban Revenue Market Share by Countries (2015-2020)
Table 39. Middle East & Africa Rivaroxaban Sales by Countries (2015-2020) (M Units)
Table 40. Middle East & Africa Rivaroxaban Sales Market Share by Countries (2015-2020)
Table 41. Middle East & Africa Rivaroxaban Revenue by Countries (2015-2020) (USD Million)
Table 42. Middle East & Africa Rivaroxaban Revenue Market Share by Countries (2015-2020)
Table 43. Global Rivaroxaban Sales by Type (2015-2020) (M Units)
Table 44. Global Rivaroxaban Sales Share by Type (2015-2020)
Table 45. Global Rivaroxaban Revenue by Type (2015-2020) (USD Million)
Table 46. Global Rivaroxaban Revenue Share by Type (2015-2020)
Table 47. Global Rivaroxaban Sales by Application (2015-2020) (M Units)
Table 48. Global Rivaroxaban Sales Share by Application (2015-2020)
Table 49. Global Rivaroxaban Sales Forecast by Regions (2021-2025) (M Units)
Table 50. Global Rivaroxaban Market Share Forecast by Regions (2021-2025)
Table 51. Global Rivaroxaban Sales Forecast by Type (2021-2025) (M Units)
Table 52. Global Rivaroxaban Market Share Forecast by Type (2021-2025)
Table 53. Global Rivaroxaban Sales Forecast by Application (2021-2025)
Table 54. Global Rivaroxaban Market Share Forecast by Application (2021-2025)
Table 55. Direct Channel Pros & Cons
Table 56. Indirect Channel Pros & Cons
Table 57. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Rivaroxaban Picture
Figure 2. Global Sales Market Share of Rivaroxaban by Type in 2019
Figure 3. 2.5 mg Picture
Figure 4. 10 mg Picture
Figure 5. 15 mg Picture
Figure 6. 20 mg Picture
Figure 7. Rivaroxaban Sales Market Share by Application in 2019
Figure 8. Acute Coronary Syndrome (ACS) Picture
Figure 9. Venous Thromboembolism (VTE) Picture
Figure 10. Global Rivaroxaban Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Rivaroxaban Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Rivaroxaban Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Rivaroxaban Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Rivaroxaban Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Rivaroxaban Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Rivaroxaban Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Rivaroxaban Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Rivaroxaban Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Rivaroxaban Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Rivaroxaban Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Rivaroxaban Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Rivaroxaban Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Rivaroxaban Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Rivaroxaban Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Rivaroxaban Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Rivaroxaban Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Rivaroxaban Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Rivaroxaban Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Rivaroxaban Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Rivaroxaban Sales Market Share by Manufacturer in 2019
Figure 31. Global Rivaroxaban Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Rivaroxaban Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Rivaroxaban Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Rivaroxaban Sales and Growth Rate (2015-2020) (M Units)
Figure 36. Global Rivaroxaban Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Rivaroxaban Revenue Market Share by Regions (2015-2020)
Figure 38. Global Rivaroxaban Revenue Market Share by Regions in 2018
Figure 39. North America Rivaroxaban Sales and Growth Rate (2015-2020)
Figure 40. Europe Rivaroxaban Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Rivaroxaban Sales and Growth Rate (2015-2020)
Figure 42. South America Rivaroxaban Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Rivaroxaban Sales and Growth Rate (2015-2020)
Figure 44. North America Rivaroxaban Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Rivaroxaban Sales Market Share by Countries (2015-2020)
Figure 46. North America Rivaroxaban Sales Market Share by Countries in 2018
Figure 47. North America Rivaroxaban Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Rivaroxaban Revenue Market Share by Countries in 2018
Figure 49. United States Rivaroxaban Sales and Growth Rate (2015-2020) (M Units)
Figure 50. Canada Rivaroxaban Sales and Growth Rate (2015-2020) (M Units)
Figure 51. Mexico Rivaroxaban Sales and Growth Rate (2015-2020) (M Units)
Figure 52. Europe Rivaroxaban Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Rivaroxaban Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Rivaroxaban Revenue Market Share by Countries in 2019
Figure 55. Germany Rivaroxaban Sales and Growth Rate (2015-2020) (M Units)
Figure 56. UK Rivaroxaban Sales and Growth Rate (2015-2020) (M Units)
Figure 57. France Rivaroxaban Sales and Growth Rate (2015-2020) (M Units)
Figure 58. Russia Rivaroxaban Sales and Growth Rate (2015-2020) (M Units)
Figure 59. Italy Rivaroxaban Sales and Growth Rate (2015-2020) (M Units)
Figure 60. Asia-Pacific Rivaroxaban Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Rivaroxaban Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Rivaroxaban Revenue Market Share by Regions 2019
Figure 63. China Rivaroxaban Sales and Growth Rate (2015-2020) (M Units)
Figure 64. Japan Rivaroxaban Sales and Growth Rate (2015-2020) (M Units)
Figure 65. Korea Rivaroxaban Sales and Growth Rate (2015-2020) (M Units)
Figure 66. India Rivaroxaban Sales and Growth Rate (2015-2020) (M Units)
Figure 67. Southeast Asia Rivaroxaban Sales and Growth Rate (2015-2020) (M Units)
Figure 68. South America Rivaroxaban Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Rivaroxaban Sales Market Share by Countries in 2019
Figure 70. South America Rivaroxaban Revenue Market Share by Countries in 2019
Figure 71. Brazil Rivaroxaban Sales and Growth Rate (2015-2020) (M Units)
Figure 72. Argentina Rivaroxaban Sales and Growth Rate (2015-2020) (M Units)
Figure 73. Middle East and Africa Rivaroxaban Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Rivaroxaban Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Rivaroxaban Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Rivaroxaban Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Rivaroxaban Sales and Growth Rate (2015-2020) (M Units)
Figure 78. Egypt Rivaroxaban Sales and Growth Rate (2015-2020) (M Units)
Figure 79. Turkey Rivaroxaban Sales and Growth Rate (2015-2020) (M Units)
Figure 80. South Africa Rivaroxaban Sales and Growth Rate (2015-2020) (M Units)
Figure 81. Global Rivaroxaban Sales and Growth Rate (2021-2025) (M Units)
Figure 82. Global Rivaroxaban Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Rivaroxaban Market Forecast (2021-2025) (M Units)
Figure 84. Europe Sales Rivaroxaban Market Forecast (2021-2025) (M Units)
Figure 85. Asia-Pacific Sales Rivaroxaban Market Forecast (2021-2025) (M Units)
Figure 86. South America Sales Rivaroxaban Market Forecast (2021-2025) (M Units)
Figure 87. Middle East & Africa Sales Rivaroxaban Market Forecast (2021-2025) (M Units)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
急性呼吸窮迫症候群治療の世界市場 2020年 Market Overview The global Acute Respiratory Distress Syndrome Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. …- 静脈ステントの世界市場 2020年 Market Overview The Venous Stents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 冠状動脈ステントの世界市場 2020年 Market Overview The Coronary Stents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
- 冠状動脈ステント装置の世界市場 2020年 Market Overview The global Coronary Stent Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Coronary Stent Devices…
- アッシャー症候群治療薬の世界市場 2020年 Market Overview The global Usher Syndrome Threapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Usher Syndrome Th…